(0.14%) 5 334.50 points
(0.06%) 40 162 points
(0.21%) 18 674 points
(-0.70%) $79.50
(2.59%) $2.69
(0.20%) $2 422.30
(0.91%) $31.55
(-2.19%) $1 066.10
(0.12%) $0.921
(0.17%) $10.69
(0.05%) $0.787
(-0.40%) $90.60
Live Chart Being Loaded With Signals
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS)...
Stats | |
---|---|
Today's Volume | 575 688 |
Average Volume | 670 703 |
Market Cap | 73.38B |
EPS | $0 ( 2024-05-07 ) |
Next earnings date | ( $0 ) 2024-07-19 |
Last Dividend | $0.620 ( 2023-12-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | 25.19 |
ATR14 | $0.197 (0.03%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-10 | Salka Susan R | Sell | 4 | Common Stock |
2024-05-10 | Salka Susan R | Sell | 606 | Common Stock |
2024-05-13 | Salka Susan R | Sell | 1 | Common Stock |
2024-03-15 | Tyler Brian S. | Buy | 3 473 | Common Stock |
2024-03-15 | Tyler Brian S. | Sell | 3 473 | Common Stock |
INSIDER POWER |
---|
-51.27 |
Last 99 transactions |
Buy: 71 595 | Sell: 254 033 |
Volume Correlation
Mckesson Corp Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Mckesson Corp Correlation - Currency/Commodity
Mckesson Corp Financials
Annual | 2024 |
Revenue: | $308.95B |
Gross Profit: | $12.20B (3.95 %) |
EPS: | $22.54 |
FY | 2024 |
Revenue: | $308.95B |
Gross Profit: | $12.20B (3.95 %) |
EPS: | $22.54 |
FY | 2023 |
Revenue: | $276.71B |
Gross Profit: | $12.36B (4.47 %) |
EPS: | $25.23 |
FY | 2022 |
Revenue: | $263.97B |
Gross Profit: | $13.13B (4.97 %) |
EPS: | $7.31 |
Financial Reports:
No articles found.
Mckesson Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.540 (N/A) |
$0.540 (N/A) |
$0.540 (N/A) |
$0.540 (N/A) |
$0.620 (N/A) |
$1.240 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.125 | 1994-12-09 |
Last Dividend | $0.620 | 2023-12-01 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-02 | |
Next Payout Date | N/A | |
# dividends | 118 | -- |
Total Paid Out | $24.02 | -- |
Avg. Dividend % Per Year | 0.59% | -- |
Score | 4.05 | -- |
Div. Sustainability Score | 5.10 | |
Div.Growth Potential Score | 3.70 | |
Div. Directional Score | 4.40 | -- |
Year | Amount | Yield |
---|---|---|
1994 | $0.125 | 0.76% |
1995 | $0.375 | 2.27% |
1996 | $0.500 | 2.02% |
1997 | $0.500 | 1.79% |
1998 | $0.500 | 0.94% |
1999 | $0.240 | 0.31% |
2000 | $0.240 | 1.02% |
2001 | $0.240 | 0.68% |
2002 | $0.240 | 0.64% |
2003 | $0.240 | 0.86% |
2004 | $0.240 | 0.78% |
2005 | $0.240 | 0.77% |
2006 | $0.240 | 0.45% |
2007 | $0.240 | 0.47% |
2008 | $0.420 | 0.66% |
2009 | $0.480 | 1.23% |
2010 | $0.660 | 1.04% |
2011 | $0.780 | 1.10% |
2012 | $0.800 | 1.01% |
2013 | $0.900 | 0.92% |
2014 | $0.960 | 0.60% |
2015 | $1.040 | 0.50% |
2016 | $1.120 | 0.58% |
2017 | $1.240 | 0.84% |
2018 | $1.460 | 0.92% |
2019 | $1.600 | 1.42% |
2020 | $1.660 | 1.20% |
2021 | $1.780 | 1.02% |
2022 | $2.02 | 0.81% |
2023 | $2.94 | 0.79% |
2024 | $0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend King | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Royal | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
SCM | Dividend Royal | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00972 | 1.500 | 9.81 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0445 | 1.200 | 8.52 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | -1.611 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0.105 | -1.000 | 8.95 | -8.95 | [0 - 1] |
currentRatioTTM | 0.916 | 0.800 | -0.419 | -0.335 | [1 - 3] |
quickRatioTTM | 0.501 | 0.800 | -1.762 | -1.409 | [0.8 - 2.5] |
cashRatioTTM | 0.0876 | 1.500 | -0.625 | -0.937 | [0.2 - 2] |
debtRatioTTM | 0.0854 | -1.500 | 8.58 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 16.13 | 1.000 | 5.14 | 5.14 | [3 - 30] |
operatingCashFlowPerShareTTM | 33.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 27.75 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | -2.92 | -1.500 | -10.00 | 10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0411 | 1.000 | -2.65 | -2.65 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0132 | 1.000 | -1.737 | -1.737 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.749 | 1.000 | 6.95 | 6.95 | [0.2 - 2] |
assetTurnoverTTM | 4.58 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 5.10 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.58 | 1.000 | 7.62 | 0 | [1 - 100] |
returnOnEquityTTM | -1.611 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 27.75 | 2.00 | 0.750 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.425 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 33.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.105 | 1.500 | 8.95 | -8.95 | [0 - 1] |
pegRatioTTM | 3.24 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0140 | 1.000 | -2.15 | 0 | [0.1 - 0.5] |
Total Score | 3.70 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Mckesson Corp
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators